My Portfolio
+
LINK YOUR PORTFOLIO

ACADIA Pharmaceuticals Inc ACAD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:15 PM EDT
20.99quote price arrow down-0.44 (-2.05%)
Volume
47,118
Close
21.43quote price arrow up+0.54 (+2.58%)
Volume
1,229,741
52 week range
19.69 - 28.35
Loading...
  • Open20.87
  • Day High21.44
  • Day Low20.76
  • Prev Close20.89
  • 52 Week High28.35
  • 52 Week High Date12/23/25
  • 52 Week Low19.69
  • 52 Week Low Date10/13/25

Key Stats

  • Market Cap3.67B
  • Shares Out171.24M
  • 10 Day Average Volume1.40M
  • Dividend-
  • Dividend Yield-
  • Beta0.83

KEY STATS

  • Open20.87
  • Day High21.44
  • Day Low20.76
  • Prev Close20.89
  • 52 Week High28.35
  • 52 Week High Date12/23/25
  • 52 Week Low19.69
  • 52 Week Low Date10/13/25
  • Market Cap3.67B
  • Shares Out171.24M
  • 10 Day Average Volume1.40M
  • Dividend-
  • Dividend Yield-
  • Beta0.83

RATIOS/PROFITABILITY

  • EPS (TTM)2.19
  • P/E (TTM)9.79
  • Fwd P/E (NTM)37.73
  • EBITDA (TTM)92.707M
  • ROE (TTM)37.32%
  • Revenue (TTM)1.095B
  • Gross Margin (TTM)91.47%
  • Net Margin (TTM)34.30%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/04/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO10:3210:32
Watch CNBC's full interview with Greenlight Capital's David Einhorn

Profile

MORE
Acadia Pharmaceuticals Inc.is a biopharmaceutical company. The Company is focused on innovation that makes the difference for underserved neurological and rare disease communities around the world. Its commercial portfolio includes the first and only FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. It is also developing therapeutic advancements with diverse pipelines that include mid- to late-stage programs in Alzheimer's disease psychosis and Lewy...
Stephen Biggar M.D., Ph.D.
Independent Chairman of the Board
Catherine Owen Adams
Chief Executive Officer, Director
Mark Schneyer
Chief Financial Officer, Executive Vice President
Thomas Garner
Executive Vice President, Chief Commercial Officer
Jennifer Rhodes J.D.
Executive Vice President, Secretary and Chief Legal Officer
Address
12830 El Camino Real, Suite 400
San Diego, CA
92130
United States